MLTX MoonLake Immunotherapeutics | $55.89
+3.2% | 9/14/2023 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 9/14/2023 |
TVTX Travere Therapeutics | $17.92
+0.7% | 5/5/2023 | - | Upgrade | Sell -> Neutral | | View details for Bryan, Garnier & Co rating of Travere Therapeutics (NASDAQ:TVTX) on 5/5/2023 |
IMCR Immunocore | $32.93
+0.8% | 3/24/2023 | - | Initiated Coverage | Buy | $16.00 | View details for Bryan, Garnier & Co rating of Immunocore (NASDAQ:IMCR) on 3/24/2023 |
IMTX Immatics | $5.69
+1.1% | 3/24/2023 | - | Initiated Coverage | Buy | $16.00 | View details for Bryan, Garnier & Co rating of Immatics (NASDAQ:IMTX) on 3/24/2023 |
ADAP Adaptimmune Therapeutics | $0.06
-2.7% | 3/24/2023 | - | Initiated Coverage | Buy | $3.60 | View details for Bryan, Garnier & Co rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 3/24/2023 |
CRSP CRISPR Therapeutics | $54.32
+2.8% | 3/17/2023 | - | Initiated Coverage | Buy | $70.00 | View details for Bryan, Garnier & Co rating of CRISPR Therapeutics (NASDAQ:CRSP) on 3/17/2023 |
CLLS Cellectis | $2.85
+2.9% | 3/17/2023 | - | Initiated Coverage | Buy | $6.00 | View details for Bryan, Garnier & Co rating of Cellectis (NASDAQ:CLLS) on 3/17/2023 |
AUTL Autolus Therapeutics | $1.75
| 3/17/2023 | - | Initiated Coverage | Buy | $5.00 | View details for Bryan, Garnier & Co rating of Autolus Therapeutics (NASDAQ:AUTL) on 3/17/2023 |
MLTX MoonLake Immunotherapeutics | $55.89
+3.2% | 2/2/2023 | - | Initiated Coverage | Buy | $22.00 | View details for Bryan, Garnier & Co rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 2/2/2023 |
SAP SAP | €232.60
+0.2% | 12/14/2022 | Gregory Ramirez | Set Price Target | | €130.00 | View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 12/14/2022 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
CRRFY Carrefour | $3.11
+0.6% | 11/16/2022 | Clement Genelot | Downgrade | Buy -> Neutral | $22.00 -> $20.00 | View details for Bryan, Garnier & Co rating of Carrefour (OTCMKTS:CRRFY) on 11/16/2022 |
TMSNY TEMENOS GROUP | $90.00
-0.3% | 10/17/2022 | Gregory Ramirez | Downgrade | Buy -> Neutral | $118.00 -> $58.00 | View details for Bryan, Garnier & Co rating of TEMENOS GROUP (OTCMKTS:TMSNY) on 10/17/2022 |
PHVS Pharvaris | $23.12
-1.0% | 10/5/2022 | - | Initiated Coverage | Buy | $16.00 | View details for Bryan, Garnier & Co rating of Pharvaris (NASDAQ:PHVS) on 10/5/2022 |
TVTX Travere Therapeutics | $17.92
+0.7% | 9/21/2022 | - | Initiated Coverage | Sell | $17.00 | View details for Bryan, Garnier & Co rating of Travere Therapeutics (NASDAQ:TVTX) on 9/21/2022 |
SGBAF SES | $6.85
-0.1% | 9/20/2022 | Thomas Coudry | Initiated Coverage | Neutral | $6.50 | View details for Bryan, Garnier & Co rating of SES (OTCMKTS:SGBAF) on 9/20/2022 |
TAP Molson Coors Beverage | $52.78
+2.0% | 9/1/2022 | Nikolaas Faes | Downgrade | Buy -> Sell | $54.00 | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 9/1/2022 |
ADRNY Ahold | €40.92
-0.8% | 8/31/2022 | Clement Genelot | Upgrade | Neutral -> Buy | €31.00 -> €34.00 | View details for Bryan, Garnier & Co rating of Ahold (OTCMKTS:ADRNY) on 8/31/2022 |
ADYEY Adyen | $17.24
+2.9% | 8/19/2022 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Adyen (OTCMKTS:ADYEY) on 8/19/2022 |
CMPGY Compass Group | $35.31
+0.9% | 6/9/2022 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Compass Group (OTCMKTS:CMPGY) on 6/9/2022 |
ZLNDY Zalando | $14.62
+4.1% | 6/1/2022 | Clement Genelot | Downgrade | Neutral -> Sell | $87.00 -> $38.00 | View details for Bryan, Garnier & Co rating of Zalando (OTCMKTS:ZLNDY) on 6/1/2022 |
GMAB Genmab A/S | $24.65
+0.9% | 5/13/2022 | Victor Floch | Upgrade | Sell -> Neutral | | View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 5/13/2022 |
NVO Novo Nordisk A/S | $56.89
+2.6% | 5/5/2022 | - | Upgrade | Sell -> Neutral | | View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 5/5/2022 |
IPSEY IPSEN | $34.09
+1.0% | 4/27/2022 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of IPSEN (OTCMKTS:IPSEY) on 4/27/2022 |
BLDR Builders FirstSource | $144.46
+8.4% | 4/6/2022 | - | Downgrade | Buy -> Neutral | $71.00 | View details for Bryan, Garnier & Co rating of Builders FirstSource (NYSE:BLDR) on 4/6/2022 |
HNNMY Hennes & Mauritz | $3.02
+3.4% | 4/4/2022 | Cedric Rossi | Downgrade | Buy -> Neutral | $225.00 -> $190.00 | View details for Bryan, Garnier & Co rating of Hennes & Mauritz (OTCMKTS:HNNMY) on 4/4/2022 |
SDXAY Sodexo | $12.67
+2.8% | 3/25/2022 | Bruno De La Rochebrochard | Downgrade | Strong-Buy -> Buy | $95.00 | View details for Bryan, Garnier & Co rating of Sodexo (OTCMKTS:SDXAY) on 3/25/2022 |
DASTY Dassault Systemes | $31.76
+2.0% | 3/25/2022 | Gregory Ramirez | Downgrade | Buy -> Neutral | $49.00 | View details for Bryan, Garnier & Co rating of Dassault Systemes (OTCMKTS:DASTY) on 3/25/2022 |
HESAY Hermes International | $245.15
+2.1% | 3/18/2022 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Hermes International (OTCMKTS:HESAY) on 3/18/2022 |
ZLNDY Zalando | $14.62
+4.1% | 3/4/2022 | - | Downgrade | Neutral | | View details for Bryan, Garnier & Co rating of Zalando (OTCMKTS:ZLNDY) on 3/4/2022 |
NVS Novartis | $126.94
+0.1% | 12/3/2021 | Jeanjacques Le | Reiterated Rating | Buy -> Neutral | $115.00 -> $85.00 | View details for Bryan, Garnier & Co rating of Novartis (NYSE:NVS) on 12/3/2021 |
AZN AstraZeneca | $80.97
+0.6% | 11/22/2021 | - | Downgrade | Buy | | View details for Bryan, Garnier & Co rating of AstraZeneca (NASDAQ:AZN) on 11/22/2021 |
NVO Novo Nordisk A/S | $56.89
+2.6% | 11/3/2021 | Jean-Jacques Le | Downgrade | Buy -> Sell | $148.00 | View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 11/3/2021 |
ESLOY EssilorLuxottica | $159.57
+1.3% | 10/29/2021 | Cedric Rossi | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of EssilorLuxottica (OTCMKTS:ESLOY) on 10/29/2021 |
BNTX BioNTech | $110.88
+0.1% | 10/5/2021 | Olga Smolentseva | Set Price Target | | $359.00 | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 10/5/2021 |
CODYY Compagnie de Saint-Gobain | $23.05
+2.5% | 10/1/2021 | Eric Lemaire | Upgrade | Neutral -> Buy | $80.00 | View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 10/1/2021 |
BNTX BioNTech | $110.88
+0.1% | 9/24/2021 | Olga Smolentseva | Set Price Target | | $451.00 | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 9/24/2021 |
VALN Valneva | $11.64
+4.0% | 9/13/2021 | Jean-Jacques Le Fur | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Valneva (NASDAQ:VALN) on 9/13/2021 |
ERFSF EUROFINS SCIENT | $81.35
+1.3% | 8/25/2021 | Bruno De | Downgrade | Strong-Buy -> Neutral | | View details for Bryan, Garnier & Co rating of EUROFINS SCIENT (OTCMKTS:ERFSF) on 8/25/2021 |
BNTX BioNTech | $110.88
+0.1% | 8/11/2021 | Olga Smolentseva | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 8/11/2021 |
BOUYF Bouygues | $44.52
| 7/27/2021 | Thomas Coudry | Upgrade | Neutral -> Buy | $37.20 | View details for Bryan, Garnier & Co rating of Bouygues (OTCMKTS:BOUYF) on 7/27/2021 |
GENIUS Act: Cancel Your Money? (Ad) A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control.
Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live. Get the free info kit with 3 strategies to sidestep digital dollar control. |
AEXAY Atos | $10.00
| 7/13/2021 | Gregory Ramirez | Downgrade | Buy -> Sell | | View details for Bryan, Garnier & Co rating of Atos (OTCMKTS:AEXAY) on 7/13/2021 |
ERFSF EUROFINS SCIENT | $81.35
+1.3% | 7/9/2021 | Bruno De | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of EUROFINS SCIENT (OTCMKTS:ERFSF) on 7/9/2021 |
LGRDY LeGrand | $30.82
+1.9% | 6/29/2021 | Eric Lemaire | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of LeGrand (OTCMKTS:LGRDY) on 6/29/2021 |
CODYY Compagnie de Saint-Gobain | $23.05
+2.5% | 6/9/2021 | Eric Lemaire | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 6/9/2021 |
MOR MorphoSys | $18.96
| 6/3/2021 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of MorphoSys (NASDAQ:MOR) on 6/3/2021 |
BNTX BioNTech | $110.88
+0.1% | 5/17/2021 | - | Reiterated Rating | Buy -> Neutral | $135.00 -> $206.00 | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 5/17/2021 |
BAYRY Bayer Aktiengesellschaft | $8.32
+2.7% | 5/13/2021 | - | Upgrade | Sell -> Neutral | | View details for Bryan, Garnier & Co rating of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) on 5/13/2021 |
BNTX BioNTech | $110.88
+0.1% | 5/11/2021 | - | Downgrade | Buy -> Neutral | $135.00 -> $206.00 | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 5/11/2021 |
BUD Anheuser-Busch InBev SA/NV | $63.85
+1.3% | 5/6/2021 | - | Upgrade | Sell -> Buy | | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 5/6/2021 |
DBVT DBV Technologies | $10.00
+4.8% | 5/3/2021 | - | Upgrade | Sell -> Buy | | View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 5/3/2021 |
AEXAY Atos | $10.00
| 4/6/2021 | - | Downgrade | Buy | | View details for Bryan, Garnier & Co rating of Atos (OTCMKTS:AEXAY) on 4/6/2021 |
ECIFY Electricité de France | $2.55
| 2/24/2021 | - | Downgrade | Neutral -> Sell | | View details for Bryan, Garnier & Co rating of Electricité de France (OTCMKTS:ECIFY) on 2/24/2021 |
GNFT GENFIT | $4.32
+4.8% | 2/12/2021 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of GENFIT (NASDAQ:GNFT) on 2/12/2021 |
IPHYF Innate Pharma | $2.06
| 2/9/2021 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Innate Pharma (OTCMKTS:IPHYF) on 2/9/2021 |
DASTY Dassault Systemes | $31.76
+2.0% | 2/5/2021 | - | Upgrade | Sell -> Buy | | View details for Bryan, Garnier & Co rating of Dassault Systemes (OTCMKTS:DASTY) on 2/5/2021 |
SDXAY Sodexo | $12.67
+2.8% | 2/3/2021 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Sodexo (OTCMKTS:SDXAY) on 2/3/2021 |
VCISY Vinci | $37.82
+1.3% | 1/14/2021 | - | Upgrade | Sell -> Neutral | | View details for Bryan, Garnier & Co rating of Vinci (OTCMKTS:VCISY) on 1/14/2021 |
IFNNY Infineon Technologies | $43.04
+2.5% | 1/14/2021 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Infineon Technologies (OTCMKTS:IFNNY) on 1/14/2021 |
STM STMicroelectronics | $27.51
+6.3% | 1/8/2021 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 1/8/2021 |
CODYY Compagnie de Saint-Gobain | $23.05
+2.5% | 1/7/2021 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 1/7/2021 |
SCRYY Scor | $3.45
+1.2% | 12/17/2020 | - | Downgrade | Buy | | View details for Bryan, Garnier & Co rating of Scor (OTCMKTS:SCRYY) on 12/17/2020 |
ITMPF Itm Power | $0.94
+4.6% | 12/11/2020 | - | Initiated Coverage | Buy | | View details for Bryan, Garnier & Co rating of Itm Power (OTCMKTS:ITMPF) on 12/11/2020 |
STM STMicroelectronics | $27.51
+6.3% | 12/10/2020 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 12/10/2020 |
IPSEY IPSEN | $34.09
+1.0% | 12/2/2020 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of IPSEN (OTCMKTS:IPSEY) on 12/2/2020 |
BAYRY Bayer Aktiengesellschaft | $8.32
+2.7% | 10/1/2020 | - | Downgrade | Neutral -> Sell | | View details for Bryan, Garnier & Co rating of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) on 10/1/2020 |
GMAB Genmab A/S | $24.65
+0.9% | 9/23/2020 | - | Downgrade | Neutral -> Sell | | View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 9/23/2020 |
IHG Intercontinental Hotels Group | $122.63
+2.2% | 9/21/2020 | - | Downgrade | Neutral -> Sell | | View details for Bryan, Garnier & Co rating of Intercontinental Hotels Group (NYSE:IHG) on 9/21/2020 |
IPHA Innate Pharma | $2.25
+0.9% | 9/9/2020 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Innate Pharma (NASDAQ:IPHA) on 9/9/2020 |
DBVT DBV Technologies | $10.00
+4.8% | 8/4/2020 | - | Downgrade | Neutral -> Sell | | View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 8/4/2020 |
BUD Anheuser-Busch InBev SA/NV | $63.85
+1.3% | 7/15/2020 | - | Downgrade | Buy -> Sell | | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 7/15/2020 |
TAP Molson Coors Beverage | $52.78
+2.0% | 7/15/2020 | - | Upgrade | Sell -> Buy | $49.00 | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 7/15/2020 |
DEO Diageo | $115.38
+0.9% | 7/8/2020 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Diageo (NYSE:DEO) on 7/8/2020 |
BNTX BioNTech | $110.88
+0.1% | 7/2/2020 | - | Boost Price Target | | $50.00 -> $62.00 | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 7/2/2020 |
STM STMicroelectronics | $27.51
+6.3% | 6/29/2020 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 6/29/2020 |
GMAB Genmab A/S | $24.65
+0.9% | 6/3/2020 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 6/3/2020 |
AZN AstraZeneca | £119.63
-0.7% | 6/2/2020 | - | Boost Price Target | Buy | GBX 8,780 -> GBX 9,100 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 6/2/2020 |
CGC Canopy Growth | $1.27
+2.4% | 6/1/2020 | - | Downgrade | Neutral -> Sell | | View details for Bryan, Garnier & Co rating of Canopy Growth (NASDAQ:CGC) on 6/1/2020 |
GNFT GENFIT | $4.32
+4.8% | 5/13/2020 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of GENFIT (NASDAQ:GNFT) on 5/13/2020 |
AZN AstraZeneca | £119.63
-0.7% | 5/11/2020 | - | Boost Price Target | Buy | GBX 8,550 -> GBX 8,780 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 5/11/2020 |
DBVT DBV Technologies | $10.00
+4.8% | 3/18/2020 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 3/18/2020 |
SGE The Sage Group | GBX 1,101
-0.1% | 3/2/2020 | - | Lower Price Target | Neutral | GBX 690 -> GBX 680 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 3/2/2020 |
BUD Anheuser-Busch InBev SA/NV | $63.85
+1.3% | 2/28/2020 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 2/28/2020 |
ACB Aurora Cannabis | $4.99
+4.4% | 2/27/2020 | - | Downgrade | Neutral -> Sell | | View details for Bryan, Garnier & Co rating of Aurora Cannabis (NASDAQ:ACB) on 2/27/2020 |
GSK GSK | GBX 1,479.50
-0.9% | 2/6/2020 | - | Lower Price Target | Neutral | GBX 1,800 -> GBX 1,773 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 2/6/2020 |
SAP SAP | €232.60
+0.2% | 1/28/2020 | - | Set Price Target | Buy | €153.00 | View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 1/28/2020 |
ASML ASML | $754.89
+2.7% | 1/14/2020 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of ASML (NASDAQ:ASML) on 1/14/2020 |
BRBY Burberry Group | GBX 1,223
+2.9% | 1/10/2020 | - | Boost Price Target | Neutral | GBX 1,780 -> GBX 1,860 | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/10/2020 |
AZN AstraZeneca | £119.63
-0.7% | 12/19/2019 | - | Reiterated Rating | Buy | | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/19/2019 |
GSK GSK | GBX 1,479.50
-0.9% | 12/19/2019 | - | Boost Price Target | Neutral | GBX 1,660 -> GBX 1,747 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 12/19/2019 |
AZN AstraZeneca | £119.63
-0.7% | 11/25/2019 | - | Upgrade | Buy | GBX 7,700 -> GBX 7,950 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/25/2019 |
GENIUS Act: Cancel Your Money? (Ad) A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control.
Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live. Get the free info kit with 3 strategies to sidestep digital dollar control. |
CABGY Carlsberg AS | $24.50
+1.2% | 8/12/2019 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Carlsberg AS (OTCMKTS:CABGY) on 8/12/2019 |
TAP Molson Coors Beverage | $52.78
+2.0% | 8/1/2019 | - | Reiterated Rating | Neutral -> Sell | $51.00 | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 8/1/2019 |
CGC Canopy Growth | $1.27
+2.4% | 7/5/2019 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Canopy Growth (NASDAQ:CGC) on 7/5/2019 |
WEED Canopy Growth | C$1.77
+1.7% | 7/4/2019 | - | Downgrade | Buy -> Neutral | C$85.00 -> C$60.00 | View details for Bryan, Garnier & Co rating of Canopy Growth (TSE:WEED) on 7/4/2019 |
AZN AstraZeneca | £119.63
-0.7% | 7/3/2019 | - | Reiterated Rating | Neutral | | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 7/3/2019 |
BURBY Burberry Group | $16.59
+4.2% | 5/20/2019 | - | Upgrade | Sell -> Neutral | | View details for Bryan, Garnier & Co rating of Burberry Group (OTCMKTS:BURBY) on 5/20/2019 |
BRBY Burberry Group | GBX 1,223
+2.9% | 5/20/2019 | - | Upgrade | Neutral | | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 5/20/2019 |
ADDYY Adidas | $100.67
+3.0% | 5/6/2019 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Adidas (OTCMKTS:ADDYY) on 5/6/2019 |
GSK GSK | GBX 1,479.50
-0.9% | 5/2/2019 | - | Lower Price Target | Neutral | GBX 1,710 -> GBX 1,660 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 5/2/2019 |
PDRDY Pernod Ricard | $47.12
| 3/29/2019 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Pernod Ricard (OTCMKTS:PDRDY) on 3/29/2019 |
AZN AstraZeneca | £119.63
-0.7% | 3/29/2019 | - | Reiterated Rating | Neutral | | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 3/29/2019 |
BAYRY Bayer Aktiengesellschaft | $8.32
+2.7% | 3/28/2019 | - | Downgrade | Neutral -> Sell | | View details for Bryan, Garnier & Co rating of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) on 3/28/2019 |
HESAY Hermes International | $245.15
+2.1% | 3/25/2019 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Hermes International (OTCMKTS:HESAY) on 3/25/2019 |
AZN AstraZeneca | £119.63
-0.7% | 2/22/2019 | - | Downgrade | Neutral | | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 2/22/2019 |
IHG InterContinental Hotels Group | GBX 8,940
+1.5% | 2/19/2019 | - | Reiterated Rating | Sell | | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 2/19/2019 |
SGE The Sage Group | GBX 1,101
-0.1% | 1/17/2019 | - | Lower Price Target | Buy | GBX 850 -> GBX 630 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/17/2019 |
AZN AstraZeneca | £119.63
-0.7% | 11/8/2018 | - | Downgrade | Neutral | | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/8/2018 |
LVMUY LVMH-Moet Hennessy Louis Vuitton | $116.13
+3.3% | 4/24/2018 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of LVMH-Moet Hennessy Louis Vuitton (OTCMKTS:LVMUY) on 4/24/2018 |
SOW Software Aktiengesellschaft | €36.68
| 4/17/2018 | - | Set Price Target | Buy | €49.00 | View details for Bryan, Garnier & Co rating of Software Aktiengesellschaft (ETR:SOW) on 4/17/2018 |
MOR MorphoSys | €67.25
| 4/9/2018 | - | Set Price Target | Buy | €91.00 | View details for Bryan, Garnier & Co rating of MorphoSys (ETR:MOR) on 4/9/2018 |
SAP SAP | €232.60
+0.2% | 4/6/2018 | - | Set Price Target | Buy | €112.00 | View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 4/6/2018 |
MOR MorphoSys | €67.25
| 3/14/2018 | - | Set Price Target | Buy | €91.20 | View details for Bryan, Garnier & Co rating of MorphoSys (ETR:MOR) on 3/14/2018 |
IGY innogy SE (IGY.F) | €43.60
| 3/12/2018 | - | Set Price Target | Neutral | €31.00 | View details for Bryan, Garnier & Co rating of innogy SE (IGY.F) (ETR:IGY) on 3/12/2018 |
IHG InterContinental Hotels Group | GBX 8,940
+1.5% | 2/20/2018 | - | Reiterated Rating | Sell | GBX 4,100 | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 2/20/2018 |
DGE Diageo | GBX 2,121
+0.2% | 1/25/2018 | - | Reiterated Rating | Neutral | GBX 2,320 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/25/2018 |
SGE The Sage Group | GBX 1,101
-0.1% | 1/25/2018 | - | Lower Price Target | Buy | GBX 860 -> GBX 850 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/25/2018 |
AZN AstraZeneca | £119.63
-0.7% | 12/15/2017 | - | Reiterated Rating | Buy | | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/15/2017 |
SGE The Sage Group | GBX 1,101
-0.1% | 11/23/2017 | - | Boost Price Target | Buy | GBX 830 -> GBX 860 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/23/2017 |
BRBY Burberry Group | GBX 1,223
+2.9% | 11/10/2017 | - | Reiterated Rating | Sell | | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 11/10/2017 |
ULVR Unilever | GBX 4,662
-0.7% | 10/20/2017 | - | Reiterated Rating | Neutral | GBX 4,350 | View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 10/20/2017 |
MBGAF Mercedes-Benz Group | $64.55
+3.1% | 9/25/2017 | - | Initiated Coverage | Buy | | View details for Bryan, Garnier & Co rating of Mercedes-Benz Group (OTCMKTS:MBGAF) on 9/25/2017 |
SGPYY Sage Group | $59.44
+0.9% | 9/24/2017 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Sage Group (OTCMKTS:SGPYY) on 9/24/2017 |
SGPYY Sage Group | $59.44
+0.9% | 9/22/2017 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Sage Group (OTCMKTS:SGPYY) on 9/22/2017 |
SGE The Sage Group | GBX 1,101
-0.1% | 9/22/2017 | - | Upgrade | Buy | GBX 720 -> GBX 830 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 9/22/2017 |
GSK GSK | GBX 1,479.50
-0.9% | 9/19/2017 | - | Reiterated Rating | Neutral | GBX 1,710 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 9/19/2017 |
TSCO Tesco | GBX 426.30
-1.2% | 9/12/2017 | - | Reiterated Rating | Sell | GBX 170 | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 9/12/2017 |
AZN AstraZeneca | £119.63
-0.7% | 9/11/2017 | - | Upgrade | Buy | GBX 4,700 -> GBX 5,380 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 9/11/2017 |
BRBY Burberry Group | GBX 1,223
+2.9% | 9/11/2017 | - | Reiterated Rating | Sell | | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 9/11/2017 |
CPG Compass Group | GBX 2,617
+0.3% | 8/29/2017 | - | Reiterated Rating | Neutral | GBX 1,550 | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 8/29/2017 |
ULVR Unilever | GBX 4,662
-0.7% | 8/25/2017 | - | Reiterated Rating | Neutral | GBX 4,300 | View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 8/25/2017 |
IHG InterContinental Hotels Group | GBX 8,940
+1.5% | 8/24/2017 | - | Reiterated Rating | Sell | GBX 3,520 | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 8/24/2017 |
DGE Diageo | GBX 2,121
+0.2% | 8/23/2017 | - | Boost Price Target | Neutral | GBX 2,210 -> GBX 2,320 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 8/23/2017 |
GSK GSK | GBX 1,479.50
-0.9% | 7/26/2017 | - | Boost Price Target | Buy | GBX 1,750 -> GBX 1,790 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 7/26/2017 |
GSK GSK | GBX 1,479.50
-0.9% | 7/20/2017 | - | Reiterated Rating | Buy | GBX 1,750 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 7/20/2017 |
TSCO Tesco | GBX 426.30
-1.2% | 6/20/2017 | - | Reiterated Rating | Sell | GBX 170 | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 6/20/2017 |
TSCO Tesco | GBX 426.30
-1.2% | 6/14/2017 | - | Reiterated Rating | Sell | GBX 170 | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 6/14/2017 |
GSK GSK | GBX 1,479.50
-0.9% | 5/31/2017 | - | Reiterated Rating | Buy | GBX 1,750 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 5/31/2017 |
BRBY Burberry Group | GBX 1,223
+2.9% | 4/20/2017 | - | Reiterated Rating | Sell | | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 4/20/2017 |
BRBY Burberry Group | GBX 1,223
+2.9% | 4/13/2017 | - | Reiterated Rating | Sell | GBX 1,350 | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 4/13/2017 |
TSCO Tesco | GBX 426.30
-1.2% | 4/13/2017 | - | Reiterated Rating | Sell | GBX 170 | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 4/13/2017 |
GENIUS Act: Cancel Your Money? (Ad) A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control.
Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live. Get the free info kit with 3 strategies to sidestep digital dollar control. |
TSCO Tesco | GBX 426.30
-1.2% | 3/23/2017 | - | Reiterated Rating | Sell | GBX 170 | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 3/23/2017 |
DGE Diageo | GBX 2,121
+0.2% | 3/17/2017 | - | Reiterated Rating | Neutral | GBX 2,210 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 3/17/2017 |
SGE The Sage Group | GBX 1,101
-0.1% | 3/6/2017 | - | Boost Price Target | Neutral | GBX 640 -> GBX 660 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 3/6/2017 |
AZN AstraZeneca | £119.63
-0.7% | 2/28/2017 | - | Reiterated Rating | Buy | GBX 5,400 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 2/28/2017 |
IHG InterContinental Hotels Group | GBX 8,940
+1.5% | 2/21/2017 | - | Reiterated Rating | Sell | GBX 2,950 | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 2/21/2017 |
CPG Compass Group | GBX 2,617
+0.3% | 2/3/2017 | - | Reiterated Rating | Neutral | GBX 1,475 | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 2/3/2017 |
SGE The Sage Group | GBX 1,101
-0.1% | 2/1/2017 | - | Reiterated Rating | Neutral | GBX 640 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 2/1/2017 |
TSCO Tesco | GBX 426.30
-1.2% | 1/30/2017 | - | Reiterated Rating | Sell | GBX 170 | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 1/30/2017 |
ULVR Unilever | GBX 4,662
-0.7% | 1/27/2017 | - | Reiterated Rating | Neutral | GBX 3,570 | View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 1/27/2017 |
DGE Diageo | GBX 2,121
+0.2% | 1/26/2017 | - | Reiterated Rating | Neutral | GBX 2,150 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/26/2017 |
SGE The Sage Group | GBX 1,101
-0.1% | 1/26/2017 | - | Reiterated Rating | Neutral | GBX 650 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/26/2017 |
BRBY Burberry Group | GBX 1,223
+2.9% | 1/18/2017 | - | Reiterated Rating | Sell | GBX 1,350 | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/18/2017 |
DGE Diageo | GBX 2,121
+0.2% | 1/16/2017 | - | Reiterated Rating | Neutral | GBX 2,150 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/16/2017 |
MRK Merck & Co., Inc. | $87.18
+1.3% | 1/13/2017 | - | Initiated Coverage | Buy | | View details for Bryan, Garnier & Co rating of Merck & Co., Inc. (NYSE:MRK) on 1/13/2017 |
BRBY Burberry Group | GBX 1,223
+2.9% | 1/10/2017 | - | Reiterated Rating | Sell | GBX 1,350 | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/10/2017 |
CPG Compass Group | GBX 2,617
+0.3% | 1/9/2017 | - | Reiterated Rating | Neutral | GBX 1,430 | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 1/9/2017 |
AZN AstraZeneca | £119.63
-0.7% | 1/9/2017 | - | Reiterated Rating | Buy | GBX 5,250 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 1/9/2017 |
GSK GSK | GBX 1,479.50
-0.9% | 1/9/2017 | - | Reiterated Rating | Buy | GBX 1,850 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 1/9/2017 |
PNN Pennon Group | GBX 492.60
+0.8% | 1/6/2017 | - | Reiterated Rating | Sell | GBX 830 | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 1/6/2017 |
BRBY Burberry Group | GBX 1,223
+2.9% | 1/4/2017 | - | Downgrade | Sell | GBX 1,350 | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/4/2017 |
DGE Diageo | GBX 2,121
+0.2% | 1/4/2017 | - | Reiterated Rating | Neutral | GBX 2,150 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/4/2017 |
ULVR Unilever | GBX 4,662
-0.7% | 1/4/2017 | - | Reiterated Rating | Neutral | GBX 3,990 | View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 1/4/2017 |
TSCO Tesco | GBX 426.30
-1.2% | 1/4/2017 | - | Reiterated Rating | Sell | GBX 170 | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 1/4/2017 |
AZN AstraZeneca | £119.63
-0.7% | 12/12/2016 | - | Reiterated Rating | Buy | GBX 5,100 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/12/2016 |
SGE The Sage Group | GBX 1,101
-0.1% | 11/30/2016 | - | Reiterated Rating | Sell | GBX 690 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/30/2016 |
CMPGY Compass Group | $35.31
+0.9% | 11/25/2016 | - | Reiterated Rating | Neutral | | View details for Bryan, Garnier & Co rating of Compass Group (OTCMKTS:CMPGY) on 11/25/2016 |
DGE Diageo | GBX 2,121
+0.2% | 11/23/2016 | - | Reiterated Rating | Neutral | | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 11/23/2016 |
AZN AstraZeneca | £119.63
-0.7% | 11/22/2016 | - | Reiterated Rating | Buy | GBX 5,100 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/22/2016 |
CPG Compass Group | GBX 2,617
+0.3% | 11/22/2016 | - | Reiterated Rating | Neutral | GBX 1,450 | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 11/22/2016 |
AZN AstraZeneca | £119.63
-0.7% | 10/26/2016 | - | Reiterated Rating | Buy | GBX 5,220 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/26/2016 |
BRBY Burberry Group | GBX 1,223
+2.9% | 10/25/2016 | - | Boost Price Target | Neutral | GBX 1,260 -> GBX 1,350 | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 10/25/2016 |
BRBY Burberry Group | GBX 1,223
+2.9% | 10/19/2016 | - | Boost Price Target | Neutral | GBX 1,200 -> GBX 1,250 | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 10/19/2016 |
AZN AstraZeneca | £119.63
-0.7% | 10/17/2016 | - | Reiterated Rating | Buy | GBX 5,220 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/17/2016 |
GSK GSK | GBX 1,479.50
-0.9% | 10/17/2016 | - | Reiterated Rating | Buy | | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 10/17/2016 |
SGE The Sage Group | GBX 1,101
-0.1% | 10/12/2016 | - | Boost Price Target | Sell | GBX 600 -> GBX 690 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 10/12/2016 |
TSCO Tesco | GBX 426.30
-1.2% | 10/5/2016 | - | Reiterated Rating | Sell | GBX 166 | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 10/5/2016 |
AZN AstraZeneca | £119.63
-0.7% | 10/4/2016 | - | Lower Price Target | Buy | GBX 5,400 -> GBX 5,220 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/4/2016 |
SGE The Sage Group | GBX 1,101
-0.1% | 9/30/2016 | - | Reiterated Rating | Sell | GBX 600 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 9/30/2016 |
IHG InterContinental Hotels Group | GBX 8,940
+1.5% | 9/27/2016 | - | Downgrade | Sell | GBX 2,650 -> GBX 2,950 | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 9/27/2016 |
AZN AstraZeneca | £119.63
-0.7% | 7/28/2016 | - | Reiterated Rating | Buy | | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 7/28/2016 |
GSK GSK | GBX 1,479.50
-0.9% | 7/28/2016 | - | Reiterated Rating | Buy | | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 7/28/2016 |
TAP Molson Coors Beverage | $52.78
+2.0% | 7/8/2016 | - | Upgrade | Buy | | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 7/8/2016 |
SGE The Sage Group | GBX 1,101
-0.1% | 5/5/2016 | - | Reiterated Rating | Sell | GBX 550 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 5/5/2016 |
TSCO Tesco | GBX 426.30
-1.2% | 4/4/2016 | - | Reiterated Rating | Neutral | GBX 166 | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 4/4/2016 |
CPG Compass Group | GBX 2,617
+0.3% | 4/4/2016 | - | Reiterated Rating | Neutral | GBX 1,200 | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 4/4/2016 |
AZN AstraZeneca | £119.63
-0.7% | 3/10/2016 | - | Reiterated Rating | Buy | GBX 5,520 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 3/10/2016 |
PNN Pennon Group | GBX 492.60
+0.8% | 2/11/2016 | - | Downgrade | Sell | GBX 825 | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 2/11/2016 |
PNN Pennon Group | GBX 492.60
+0.8% | 2/4/2016 | - | Reiterated Rating | Neutral | GBX 800 | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 2/4/2016 |
SGE The Sage Group | GBX 1,101
-0.1% | 1/28/2016 | - | Reiterated Rating | Neutral | GBX 570 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/28/2016 |
GSK GSK | $40.15
+0.2% | 1/27/2016 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of GSK (NYSE:GSK) on 1/27/2016 |
9 AI Stocks Set to Soar Amid U.S.-China Trade Tensions (Ad) The escalating U.S.-China trade tensions are reshaping the AI landscape. Companies like Nvidia are facing significant revenue hits with the U.S. imposing new export restrictions on advanced AI chips to China.
This shift opens doors for U.S.-based AI companies poised to fill the gap. I've identified 9 under-the-radar AI stocks - get your copy today |
GSK GSK | GBX 1,479.50
-0.9% | 1/27/2016 | - | Upgrade | Buy | GBX 1,635 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 1/27/2016 |
ASML ASML | $754.89
+2.7% | 1/21/2016 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of ASML (NASDAQ:ASML) on 1/21/2016 |
TSCO Tesco | GBX 426.30
-1.2% | 1/14/2016 | - | Initiated Coverage | Neutral | GBX 166 | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 1/14/2016 |
PNN Pennon Group | GBX 492.60
+0.8% | 1/8/2016 | - | Reiterated Rating | Neutral | GBX 800 | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 1/8/2016 |
IHG InterContinental Hotels Group | GBX 8,940
+1.5% | 1/7/2016 | - | Reiterated Rating | Neutral | GBX 2,650 | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 1/7/2016 |
CPG Compass Group | GBX 2,617
+0.3% | 1/5/2016 | - | Boost Price Target | Neutral | GBX 1,150 -> GBX 1,200 | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 1/5/2016 |
SGE The Sage Group | GBX 1,101
-0.1% | 12/18/2015 | - | Reiterated Rating | Neutral | GBX 540 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 12/18/2015 |
DGE Diageo | GBX 2,121
+0.2% | 12/3/2015 | - | Reiterated Rating | Neutral | GBX 1,870 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 12/3/2015 |
TSCO Tesco | GBX 426.30
-1.2% | 12/1/2015 | - | Reiterated Rating | Neutral | | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 12/1/2015 |
PNN Pennon Group | GBX 492.60
+0.8% | 11/27/2015 | - | Reiterated Rating | Neutral | GBX 800 | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 11/27/2015 |
SGE The Sage Group | GBX 1,101
-0.1% | 11/27/2015 | - | Reiterated Rating | Neutral | GBX 540 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/27/2015 |
TSCDY Tesco | $17.47
-0.5% | 11/25/2015 | - | Reiterated Rating | Neutral | | View details for Bryan, Garnier & Co rating of Tesco (OTCMKTS:TSCDY) on 11/25/2015 |
TSCO Tesco | GBX 426.30
-1.2% | 11/25/2015 | - | Initiated Coverage | Neutral | | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 11/25/2015 |
CPG Compass Group | GBX 2,617
+0.3% | 11/24/2015 | - | Reiterated Rating | Neutral | GBX 1,150 | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 11/24/2015 |
TAP Molson Coors Beverage | $52.78
+2.0% | 11/17/2015 | - | Initiated Coverage | Buy | $101.00 | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 11/17/2015 |
SGE The Sage Group | GBX 1,101
-0.1% | 11/13/2015 | - | Reiterated Rating | Neutral | GBX 540 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/13/2015 |
AZN AstraZeneca | £119.63
-0.7% | 11/12/2015 | - | Boost Price Target | Buy | GBX 5,100 -> GBX 5,150 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/12/2015 |
SNY Sanofi | $51.35
+1.5% | 11/9/2015 | - | Reiterated Rating | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of Sanofi (NASDAQ:SNY) on 11/9/2015 |
PNN Pennon Group | GBX 492.60
+0.8% | 10/26/2015 | - | Reiterated Rating | Neutral | GBX 800 | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 10/26/2015 |
AZN AstraZeneca | £119.63
-0.7% | 10/23/2015 | - | Reiterated Rating | Buy | GBX 5,100 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/23/2015 |
UBSFY UbiSoft Entertainment | $2.16
+3.3% | 10/15/2015 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of UbiSoft Entertainment (OTCMKTS:UBSFY) on 10/15/2015 |
AZN AstraZeneca | £119.63
-0.7% | 10/12/2015 | - | Reiterated Rating | Buy | GBX 5,400 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/12/2015 |
SGE The Sage Group | GBX 1,101
-0.1% | 10/6/2015 | - | Reiterated Rating | Neutral | GBX 520 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 10/6/2015 |
IHG InterContinental Hotels Group | GBX 8,940
+1.5% | 10/5/2015 | - | Reiterated Rating | Neutral | | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 10/5/2015 |
DGE Diageo | GBX 2,121
+0.2% | 10/1/2015 | - | Reiterated Rating | Neutral | GBX 1,870 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 10/1/2015 |
DGE Diageo | GBX 2,121
+0.2% | 9/23/2015 | - | Lower Price Target | Neutral | GBX 1,920 -> GBX 1,870 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 9/23/2015 |
AZN AstraZeneca | $80.97
+0.6% | 9/18/2015 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of AstraZeneca (NASDAQ:AZN) on 9/18/2015 |
AZN AstraZeneca | £119.63
-0.7% | 9/10/2015 | - | Reiterated Rating | Neutral | GBX 4,830 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 9/10/2015 |
GSK GSK | GBX 1,479.50
-0.9% | 9/9/2015 | - | Lower Price Target | Neutral | GBX 1,480 -> GBX 1,470 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 9/9/2015 |
PNN Pennon Group | GBX 492.60
+0.8% | 8/25/2015 | - | Reiterated Rating | Neutral | GBX 835 | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 8/25/2015 |
GSK GSK | GBX 1,479.50
-0.9% | 8/21/2015 | - | Reiterated Rating | Neutral | GBX 1,480 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 8/21/2015 |
AZN AstraZeneca | £119.63
-0.7% | 8/21/2015 | - | Reiterated Rating | Neutral | GBX 4,830 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 8/21/2015 |
DGE Diageo | GBX 2,121
+0.2% | 7/29/2015 | - | Reiterated Rating | Neutral | GBX 1,920 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 7/29/2015 |
SGE The Sage Group | GBX 1,101
-0.1% | 7/21/2015 | - | Reiterated Rating | Neutral | GBX 520 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 7/21/2015 |
VCISY Vinci | $37.82
+1.3% | 7/17/2015 | - | Initiated Coverage | Buy | | View details for Bryan, Garnier & Co rating of Vinci (OTCMKTS:VCISY) on 7/17/2015 |
DANOY Danone | $17.16
+0.1% | 7/8/2015 | - | Initiated Coverage | Buy | | View details for Bryan, Garnier & Co rating of Danone (OTCMKTS:DANOY) on 7/8/2015 |
DGE Diageo | GBX 2,121
+0.2% | 7/2/2015 | - | Reiterated Rating | Neutral | GBX 1,920 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 7/2/2015 |
DASTY Dassault Systemes | $31.76
+2.0% | 6/30/2015 | - | Downgrade | Neutral -> Sell | | View details for Bryan, Garnier & Co rating of Dassault Systemes (OTCMKTS:DASTY) on 6/30/2015 |
NVS Novartis | $126.94
+0.1% | 6/22/2015 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Novartis (NYSE:NVS) on 6/22/2015 |
IFNNY Infineon Technologies | $43.04
+2.5% | 6/11/2015 | - | Initiated Coverage | Buy | | View details for Bryan, Garnier & Co rating of Infineon Technologies (OTCMKTS:IFNNY) on 6/11/2015 |
DLGNF Dialog Semiconductor | $80.41
| 6/11/2015 | - | Initiated Coverage | Buy | | View details for Bryan, Garnier & Co rating of Dialog Semiconductor (OTCMKTS:DLGNF) on 6/11/2015 |
GSK GSK | GBX 1,479.50
-0.9% | 6/2/2015 | - | Reiterated Rating | Neutral | GBX 1,580 | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 6/2/2015 |
IHG InterContinental Hotels Group | GBX 8,940
+1.5% | 5/21/2015 | - | Reiterated Rating | Neutral | GBX 2,650 | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 5/21/2015 |
UBSFY UbiSoft Entertainment | $2.16
+3.3% | 5/13/2015 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of UbiSoft Entertainment (OTCMKTS:UBSFY) on 5/13/2015 |
DGE Diageo | GBX 2,121
+0.2% | 5/6/2015 | - | Reiterated Rating | Neutral | GBX 1,950 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 5/6/2015 |
HEINY Heineken | $41.37
+1.1% | 5/5/2015 | - | Initiated Coverage | Buy | | View details for Bryan, Garnier & Co rating of Heineken (OTCMKTS:HEINY) on 5/5/2015 |
CABGY Carlsberg AS | $24.50
+1.2% | 5/5/2015 | - | Initiated Coverage | Neutral | | View details for Bryan, Garnier & Co rating of Carlsberg AS (OTCMKTS:CABGY) on 5/5/2015 |
BUD Anheuser-Busch InBev SA/NV | $63.85
+1.3% | 5/5/2015 | - | Initiated Coverage | Neutral | | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 5/5/2015 |
AEG Aegon | $7.95
-1.1% | 4/15/2015 | - | Upgrade | Neutral -> Buy | | View details for Bryan, Garnier & Co rating of Aegon (NYSE:AEG) on 4/15/2015 |
RANJY Randstad | $24.35
+3.1% | 4/14/2015 | - | Upgrade | Sell -> Buy | | View details for Bryan, Garnier & Co rating of Randstad (OTCMKTS:RANJY) on 4/14/2015 |
AZN AstraZeneca | £119.63
-0.7% | 4/10/2015 | - | Reiterated Rating | Neutral | GBX 4,740 | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 4/10/2015 |
DGE Diageo | GBX 2,121
+0.2% | 4/1/2015 | - | Boost Price Target | Neutral | GBX 1,880 -> GBX 2,000 | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 4/1/2015 |
CPG Compass Group | GBX 2,617
+0.3% | 3/30/2015 | - | Boost Price Target | Neutral | GBX 1,070 -> GBX 1,220 | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 3/30/2015 |
NVO Novo Nordisk A/S | $56.89
+2.6% | 3/26/2015 | - | Downgrade | Neutral | | View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 3/26/2015 |
PPRUY Kering | $26.15
+3.3% | 2/18/2015 | - | Downgrade | Neutral | | View details for Bryan, Garnier & Co rating of Kering (OTCMKTS:PPRUY) on 2/18/2015 |
LVMUY LVMH-Moet Hennessy Louis Vuitton | $116.13
+3.3% | 2/4/2015 | - | Upgrade | Buy | | View details for Bryan, Garnier & Co rating of LVMH-Moet Hennessy Louis Vuitton (OTCMKTS:LVMUY) on 2/4/2015 |
SGE The Sage Group | GBX 1,101
-0.1% | 1/29/2015 | - | Reiterated Rating | Neutral | GBX 450 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/29/2015 |
RHHBY Roche | $40.87
+1.0% | 1/28/2015 | - | Upgrade | Buy | | View details for Bryan, Garnier & Co rating of Roche (OTCMKTS:RHHBY) on 1/28/2015 |
SAP SAP | $270.96
+0.7% | 1/20/2015 | - | Downgrade | Buy -> Neutral | | View details for Bryan, Garnier & Co rating of SAP (NYSE:SAP) on 1/20/2015 |
SGE The Sage Group | GBX 1,101
-0.1% | 1/13/2015 | - | Reiterated Rating | Neutral | GBX 420 | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/13/2015 |
MarketBeat All Access